Four new labdane-type diterpenoid glycosides from Diplopterygium laevissimum by Ming-Ming Li et al.
Regular Article                                                                                                                                     Nat. Prod. Bioprospect. 2013, 3, 38–42 
DOI 10.1007/s13659-012-0022-3 
 
         
Four new labdane-type diterpenoid glycosides from  
Diplopterygium laevissimum 
Ming-Ming LI, Kou WANG, Juan HE, Li-Yan PENG, Xuan-Qin CHEN, Xiao CHENG, and  
Qin-Shi ZHAO* 
State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese  
Academy of Sciences, Kunming 650201, China 
 
Received 13 March 2012; Accepted 24 February 2013 
© The Author(s) 2012. This article is published with open access at Springerlink.com 
 
Abstract: Four new labdane-type diterpenoid glycosides, laevissiosides A–D (1–4) were isolated from the 95% ethanol extract of 
Diplopterygium laevissimum (Christ) Nakai, along with two known analogues, 18--D-glucopyranosyl ester-sclareol (5) and 18-
hydroxy-sclareol (6). The structures of compounds 1–4 were elucidated by extensive 1D and 2D NMR spectroscopy as well as 
high-resolution MS analyses. All isolated compounds were evaluated for their cytotoxic effects. 
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Introduction 
Diplopterygium laevissimum (Christ) Nakai, belonging to 
the Gleicheniaceae family, is widely distributed in south China. 
Its rhizome has been used for treating hemostasis, stomach, 
and epistaxis as Chinese herbal medicine.1 Many clerodane- 
and labdane-type diterpenoid glycosides, which are commonly 
glycosidated at C-13 in ferns, have been isolated from this 
family.2–8 Previous research showed that some clerodane-type 
diterpenoid glycosides isolated from Dicranopteris species 
could accelerate the growth of the stems of lettuce and inhibit 
the root growth.5 
Our previous chemical studies have led to the isolation of 
two highly oxygenated phenolic derivatives and some  
clerodane-type diterpenoid glycosides from Dicranopteris and 
an ent-kaurene diterpenoid glycoside from Hicriopteris.6,9–11 
As a systematic research work on the bioactive constituents 
from the ferns, the whole plant of D. laevissimum had been 
studied, which led to the isolation of four new labdane-type 
diterpenoid glycosides (1–4), along with two known analogues 
(5 and 6). All of these showed no in vitro cytotoxicity against 
five human cancer cell lines (HL-60, SMMC-7712, A-549, 
SK-BR-3 and PANC-1). Herein, the isolation and structure 
elucidation of compounds 14 were described. 
 
Results and Discussion 
Compound 1 was obtained as a white amorphous powder. 
The molecular formula C35H52O10 was established by the 
HRESIMS (631.3471 [M – H]–; calcd. 631.3482), 
corresponding to ten degrees of unsaturation. The IR spectrum 
showed the presence of hydroxyl (3428 cm–1) and carbonyl 
(1704 cm–1) groups. The 1H and 13C NMR (Tables 1 and 2) 
indicated the existence of a set of signals for a hexose 
[anomeric signals at δH 4.30 (d, J = 8.0 Hz); δC 104.6] and 
other 20 carbon resonances, including two olefinic carbons (δC 
147.5 and 110.8) and three oxygen-bearing carbons (δC 73.4, 
73.9 and 79.2). These data were very similar to those of 18--
D-glucopyranosyl ester-sclareol (5), a known compound also 
isolated from this plant. However, detailed comparison the MS 
and NMR data of 1 with those of 5 revealed that 1 had one 
more p-coumaroyl group, which was attached to C-4′ of the 
sugar moiety as concluded from the HMBC (Figure 1) 
correlations of H-4′ (δH 4.84) with C-1′′ (δC 167.4). The double 
bond of the p-coumaroyl group was suggested as trans- due to 
the coupling constant (J = 15.6 Hz). Acidic hydrolysis of 1 
gave D-glucose as sugar residue. The coupling constants of the 
anomeric proton (J = 8.0 Hz) indicated the β configuration of 
glucosyl moiety. Assignment of glycosidic protons system was 


































1 R1 = Glc-(4-1)-E-p-coumaroyl, R2 = H
2 R1 = Glc-(2-1)-Rha, R2 = H
3 R1 = Glc-(2-1)-Rha, R2 = Fuc
5 R1 = Glc, R2 = H



















*To whom correspondence should be addressed. E-mail: 
qinshizhao@mail.kib.ac.cn 
M. M. LI et al.                                                                                                                             Nat. Prod. Bioprospect. 2013, 3, 38–42      39 
 
         
of the sugar unit was established by the HMBC correlations of 
H-1′ (δH 4.30) with C-18 (δC 79.2). 
The relative configuration of the aglycone was established 
on a ROESY experiment. The ROESY correlations (Figure 2) 
between H-5 and H-9 confirmed that these hydrogen atoms 
were α-oriented, while correlations of H-11/Me-17, H-11/Me-
20, Me-17/Me-19, Me-17/Me-20, and Me-19/Me-20 indicated 
they were β-orientation. The absolute configuration of C-13 
was inferred as S according to the chmical shift of C-13 (δC 
73.4).12–14 Therefore, the structure of 1 was determined as 
shown, named laevissioside A. 
Compound 2, a white amorphous powder, and its molecular 
formula, C32H56O12, was determined on the basis of the 
HRESIMS (667.3454 [M + Cl]–; calcd. 667.3460). The 1H and 
13C NMR spectroscopic data of 2 were very similar to those of 
5, except for one more sugar moiety signals (δC 100.8, 72.0, 
71.7, 73.7, 69.2, 18.3) presented in 2 which was further 
confirmed by mass spectra. Acidic hydrolysis of 2 gave D-
glucose and L-rhamnose as sugar residues. The coupling 
constants (δH 4.27, J = 7.5 Hz and δH 5.51, J = 1.5 Hz) of 
anomeric protons of the two sugar moieties indicated the β 
configuration glucose and α configuration of rhamnose. The 
HMBC correlations between H-1′′ (δH 5.51) and C-2′ (δC 77.5) 
identified a rhamnosyl (1→2) glucopyranosyl linkage. 
Furthermore, the sugar chain was linked to C-18 of the 
aglycone as inferred from the HMBC (Figure 1) correlation of 
Table 1. 1H NMR data of compounds 1–4 (δ in ppm, J in Hz) 
no. 1a no. 2a 3b 4a,c 
1 1.66 (m); 0.95 (m) 1 1.59 (m); 1.09 (m) 1.59 (m); 1.04 (m) 1.79 (m); 1.13 (m) 
2 1.63 (m); 1.42 (m) 2 1.59 (m); 1.41 (m)  1.60 (m); 1.45 (m) 1.69 (m); 1.51 (m) 
3 1.56 (m); 1.27 (m) 3 1.59 (m); 1.18 (m)  1.50 (m); 1.30 (m) 1.48 (m); 1.40 (m) 
5 1.48 (m) 5 1.36 (m) 1.38 (m) 1.32 (m) 
6 1.55 (m); 1.25 (m) 6 1.52 (m); 1.27 (m) 1.55 (m); 1.36 (m) 1.62 (m); 1.32 (m) 
7 1.70 (m); 1.26 (m)  7 1.74 (m); 1.52 (m)  1.75 (m); 1.47 (m) 1.80 (m); 1.50 (m) 
9 1.16 (m) 9 1.35 (m) 1.24 (m) 1.00 (m) 
11 1.33 (m) 11 1.47 (m); 1.29 (m)  1.50 (m); 1.36 (m)  1.43 (m) 
12 1.73 (m); 1.55 (m) 12 1.78 (m); 1.56 (m) 1.62 (m); 1.51 (m) 1.76 (m); 1.54 (m) 
14 5.91 (dd, 10.8, 17.6) 14 5.89 (dd,10.5, 17.0) 5.91 (dd, 10.8, 17.6) 5.88 (dd, 10.8, 18.0) 
15 4.92 (d, 10.8); 5.19 (d, 17.6) 15 5.15 (d, 17.0); 4.91(d, 10.5) 5.17 (d, 17.6); 5.15 (d, 10.8) 5.18 (m); 5.16 (m) 
16 1.20 (s) 16 1.05 (s) 1.09 (s) 1.09 (s) 
17 1.10 (s) 17 1.19 (s) 1.32 (s) 1.32 (s) 
18 3.45 (m); 3.25 (m) 18 3.38 (m); 3.20 (m) 3.48 (m); 3.21 (m) 3.44 (m); 3.35 (m) 
19 0.75 (s) 19 0.70 (s) 0.76 (s) 0.81 (s) 
20 0.82 (s) 20 0.79 (s) 0.82 (s) 0.85 (s) 
1 4.30 (d, 8.0) 1 4.27 (d, 7.5) 4.25 (d, 7.2) 4.42 (d, 7.2) 
2 3.33 (m) 2 3.24 (m) 3.45 (m) 3.53 (m) 
3 3.68 (m) 3 3.52 (m) 3.46 (m) 3.68 (m) 
4 4.84 (t, 9.6) 4 3.26 (m) 3.24 (m) 3.36 (m) 
5 3.48 (m) 5 3.48 (m) 3.19 (m) 3.35 (m) 
6 3.54 (m); 3.58 (m) 6 3.79 (m); 3.62 (m) 3.64 (m); 3.83 (m) 3.68 (m); 3.84 (m) 
2 6.36 (d, 15.6) 1 5.51 (d, 1.5) 5.42 (d, 1.5) 5.62 (d, 0.8) 
3 7.64 (d, 15.6) 2 3.87 (m) 3.91 (m) 5.32 (m) 
5/9 7.55 (d, 8.8) 3 3.77 (m) 3.74 (m) 5.15 (m) 
6/8 6.90 (d, 8.8) 4 3.43 (m) 3.40 (m) 5.12 (m) 
  5 4.08 (m) 4.06 (m) 4.46 (m) 
  6 1.25 (d, 6.5) 1.27 (d, 6.0) 1.18 (d, 6.4) 
  1″′  4.28 (d, 8.0) 4.52 (d, 8.0) 
  2″′  3.41 (m) 5.37 (m) 
  3″′  3.40 (m) 3.87 (m) 
  4″′  3.55 (m) 4.92 (m) 
  5″′  3.52 (m) 3.82 (m) 
  6″′  1.20 (d, 6.4) 1.08 (d, 6.4) 
aMeasured in acetone-d6. bDetermined in CD3OD. cAcetyl groups H: (1.98, 2.06, 2.13, 2.13, 2.16). 
 
Figure 1.  Selected HMBC correlations of compound 1 and 2 
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H-1′ (δH 4.27) with C-18 (δC 78.2). Thus, the structure of 2 
was elucidated and named as laevissioside B. 
Compound 3, obtained as a white amorphous powder, had 
the molecular formula C38H66O16 as determined by the analysis 
of 1H, 13C, and DEPT NMR data and verified by the 
HRESIMS (813.4042 [M + Cl]–; calcd. 813.4039). Compared 
with 2, compound 3 had one more sugar moiety (δC 99.6, 72.4, 
75.2, 73.0, 71.5, and 17.0) which was attached to C-13 as 
inferred from the HMBC correlations from H-1′′′ to C-13. 
Acidic hydrolysis of 3 gave D-glucose, L-rhamnose, and D-
fucose as sugar residues. They were in , α and  
configurations, respectively, by the coupling constants (δH 
4.25, J = 7.2 Hz, δH 5.42, J = 1.5 Hz, and δH 4.28, J = 8.0 Hz) 
of their anomeric protons. The sugar moiety linked to C-13 
was supposed to be fucose by the HMBC correlations of the 
anomeric proton H-1′′′ (δH 4.28) with C-13 (δC 81.8). The 
linkage and location of the other two sugar moieties were 
suggested the same as compound 2 deduced from the HMBC 
correlations. Accordingly, the structure of 3 was established as 
shown, named laevissioside C. 
The molecular formula of compound 4 was deduced as 
C48H76O21 by the HRESIMS (1023.4557 [M + Cl]–; calcd 
1023.4567). The 1H and 13C NMR features of 4 were closely 
related to those of 3. The only difference was that there were 
five more acetyl groups in 4. The locations of acetyl groups 
were confirmed by the HMBC experiments. The correlations 
of H-2′′′ (δH 5.37) with δC 170.4, H-4′′′ (δH 4.92) with δC 170.0, 
H-2′′ (δH 5.32) with δC 171.5, H-3′′ (δH 5.15) with δC171.0, and 
H-4′′ (δH 5.12) with δC 170.6 indicated the five acetyl groups 
attached to C-2′′′, C-4′′′, C-2′′, C-3′′, and C-4′′, respectively. 
Therefore, the structure of 4 was identified and named as 
laevissioside D. 
Since the known compounds 18--D-glucopyranosyl ester-
sclareol (5, [α]24.3D    27.7) and 18-hydroxy-sclareol (6, [α]24.3D    
4.7), whose physical properites were quite difference with that 
reported,15,16 were also isolated from this plant, compounds  
1–4 should be labdane-type diterpenoid glycosides from the 
biogenic view. 
All compounds isolated were evaluated for their cytotoxic 
activity against five human cancer cell lines, HL-60 myeloid 
leukemia, SMMC-7721 hepatocellular carcinoma, A-549 lung 
cancer, SK-BR-3 breast cancer, PANC-1 pancreatic cancer, 
applying the MTT method. However, all of the compounds 
were inactive, and they showed IC50 values > 40 μM. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Horiba SEPA-300 polarimeter. IR spectra were 
obtained by Tensor 27 FT-IR spectrometer with KBr pellets. 
The 1H and 13C NMR spectra were recorded on Bruker AV-
400 spectrometers in acetone-d6 at room temperature (δ in ppm, 
J in Hz). FABMS was carried out on a VG Autospec-3000 
spectrometer. HRESIMS was recorded with an API QSTAR 
Pulsar i spectrometer. Silica gel (200–300 mesh), Silica gel H 
(Qingdao Marine Chemical Ltd., China), and LiChroprep RP-
18 silica gel (40–63 μm, Merck, Dramstadt, Germany) were 
used for column chromatography. Fractions were monitored 
by TLC and spots visualized by heating silica gel plates  
immersed with 15% H2SO4 in ethanol. Solvents were distilled 
prior to use. Preparative HPLC was performed on a Shimadzu 
Table 2. 13C NMR data of compounds 1-4 ( δ in ppm) 
no. 1a no. 2a 3b 4a,c 
1 39.8 CH2 1 39.7 CH2 40.4 CH2 39.5 CH2
2 18.5 CH2 2 18.4 CH2 18.8 CH2 18.4 CH2
3 36.6 CH2 3 36.5 CH2 37.0 CH2 36.4 CH2
4 37.9 C 4 37.8 C 38.3 C 38.2 C 
5 49.6 CH 5 48.9 CH 50.7 CH 51.2 CH 
6 21.0 CH2 6 20.9 CH2 21.4 CH2 21.5 CH2
7 44.6 CH2 7 44.7 CH2 44.8 CH2 45.4 CH2
8 73.9 C 8 74.6 C 75.4 C 73.8 C 
9 62.1 CH 9 60.9 CH 62.0 CH 62.9 CH 
10 40.0 C 10 40.0 C 40.4 C 40.0 C 
11 20.1 CH2 11 20.4 CH2 20.5 CH2 19.9 CH2
12 46.5 CH2 12 45.7 CH2 44.8 CH2 46.7 CH2
13 73.4 C 13 73.7 C 81.8 C 80.7 C 
14 147.5 CH 14 147.0 CH 145.0 CH 143.5 CH 
15 110.8 CH2 15 111.1 CH2 115.2 CH2 115.5 CH2
16 28.1 CH3 16 23.6 CH3 23.0 CH3 23.8 CH3
17 24.6 CH3 17 27.3 CH3 23.7 CH3 24.6 CH3
18 79.2 CH2 18 78.2 CH2 79.4 CH2 79.0 CH2
19 17.9 CH3 19 18.2 CH3 18.2 CH3 17.9 CH3
20 16.2 CH3 20 16.2 CH3 16.5 CH3 16.3 CH3
1 104.6 CH 1 102.9 CH 103.5 CH 102.5 CH 
2 75.2 CH 2 77.5 CH 78.0 CH 75.9 CH 
3 75.5 CH 3 79.6 CH 79.8 CH 79.3 CH 
4 72.3 CH 4 71.9 CH 72.0 CH 72.1 CH 
5 75.8 CH 5 76.8 CH 77.9 CH 77.5 CH 
6 62.4 CH2 6 62.6 CH2 62.7 CH2 62.5 CH2
1 167.4 C 1 100.8 CH 101.5 CH 97.8 CH 
2 115.2 CH 2 72.0 CH 72.3 CH 70.5 CH 
3 146.1 CH 3 71.7 CH 72.1 CH 71.0 CH 
4 121.8 C 4 73.7 CH 74.0 CH 74.0 CH 
5/9 116.7 CH 5 69.2 CH 70.0 CH 67.1 CH 
6/8 131.0 CH 6 18.3 CH3 18.8 CH3 17.6 CH3
7 160.8 C 1″′  99.6 CH 97.1 CH 
  2″′  72.4 CH 70.1 CH 
  3″′  75.2 CH 71.1 CH 
  4″′  73.0 CH 73.4 CH 
  5″′  71.5 CH 69.5 CH 
  6″′  17.0 CH3 16.9 CH3
aMeasured in acetone-d6. bDetermined in CD3OD. cAcetyl groups 
(C: C=O 170.0, 170.4, 170.6, 171.0, 171.5; Me: 20.7, 20.8, 21.2, 
21.2, 21.2). 
 
Figure 2.  Significant ROESY correlations of compounds 14 
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LC-8A preparative liquid chromatograph with Shimadzu PRC-
ODS (K) column. Sephadex LH-20 (Amersham Pharmacia 
biotech, Sweden). 
 
Plant Material. The aerial parts of D. laevissimum were 
collected from Pingbian, Yunnan Province, China in July 2007 
and identified by Professor Xiao Cheng at Kunming Institute 
of Botany, Chinese Academy of Sciences. A voucher  
specimen (No. 200707A03) has been deposited in the State 
Key Laboratory of Phytochemistry and Plant Resources in 
West China, Kunming Institute of Botany, Chinese Academy 
of Sciences. 
 
Extraction and Isolation. The dried and powdered plant 
materials (2.6 kg) were extracted with 95% ethanol (15.0 L, 
each 2 d) for three times. After evaporation of the solvent in 
vacuo, the concentrate was suspended into H2O and  
partitioned successively with ethyl acetate. The ethyl acetate 
extract (120 g) was chromatographed on a silica gel column 
eluted with CHCl3-MeOH (1:0 to 5:5) to give five fractions 
15. Fraction 2 was subjected to column chromatograph (CC) 
over silica gel (petroleum ether-acetone 8.5:1.5) and further 
purified by recrystallization to obtain 6 (20 mg). Fraction 3 
was eluted with CHCl3-MeOH (9:1) over silica gel CC then 
further purified by RP-18 and Sephadex LH-20 to yield 1 (3 g), 
4 (500 mg), and 5 (2 g). Fraction 4 was subjected to 
(CHCl3:MeOH = 8.5:1.5) and further purified by RP-18 and 
Sephadex LH-20 to afford 2 (8 mg) and 3 (20 mg). 
 
Laevissioside A: amorphous powder; [α] 19.2D    50.4 (c = 
0.14, MeOH). UV (MeOH) λmax (log ): 314 (4.18), 227 (3.94), 
211 (3.95), 200 (3.99), 192 (3.91) nm. IR (KBr): 3428, 2931, 
1704, 1630, 1604, 1515, 1450, 1387, 1162, 1066, 1031 cm–1. 
1H and 13C NMR: see Table 1. FABMS (neg.) m/z: 631 [M  
H]. HRESIMS (neg.) m/z: 631.3471 (C35H51O10; calcd. 
631.3482). 
 
Laevissioside B: amorphous powder; [α] 26.4D    62.2 (c = 
0.18, MeOH). UV (MeOH) λmax (log ): 203 (3.38), 194 (3.12) 
nm. IR (KBr): 3423, 2927, 1069, 1052 cm–1. 1H and 13C NMR: 
see Table 2. FABMS (neg.) m/z: 631 [M  H]. HRESIMS 
(neg.) m/z: 667.3454 (C32H56O12Cl; calcd. 667.3460). 
 
Laevissioside C: amorphous powder; [α] 18.9D    11.2 (c = 
0.10, MeOH). UV (MeOH) λmax (log ): 201 (3.31), 191 (3.10) 
nm. IR (KBr): 3431, 2926, 1704, 1638, 1384, 1169, 1128, 
1054 cm–1. 1H and 13C NMR: see Table 2. FABMS (neg.) m/z: 
777 [M  H], 631 [M  146  H]. HRESIMS (neg.) m/z: 
813.4042 (C38H66O16Cl; calcd. 813.4039). 
 
Laevissioside D: amorphous powder; [α] 26.6D    58.3 (c = 
0.25, MeOH). UV (MeOH) λmax (log ): 199 (3.07), 192 (3.12) 
nm. IR (KBr): 3442, 2935, 1749, 1373, 1228, 1062, 1062 cm–1. 
1H and 13C NMR: see Table 2. Acetyl groups (C: C=O 170.0, 
170.4, 170.6, 171.0, 171.5; Me: 20.7, 20.8, 21.2, 21.2, 21.2) H: 
(1.98, 2.06, 2.13, 2.13, 2.16). FABMS (neg.) m/z: 987 [M  
H]. HRESIMS (neg.) m/z: 1023.4557 (C48H76O21Cl; calcd. 
1023.4567). 
 
Acidic Hydrolysis of Compounds 13. Compounds 13 
(68 mg) were hydrolyzed with 2 M HCl-dioxane (1:1, 4 mL) 
under reflux for 6 h. The reaction mixture was extracted with 
CHCl3 five times (4 mL × 5). The aqueous layer was neutral-
ized with 2 M NaHCO3, and was evaporated to dryness. The 
dry powders were dissolved in pyridine (2 mL). Then  
L-cysteine methyl ester hydrochloride (about 1.5 mg) was 
added and kept at 60 °C for 1 h. Next, trimethylsilylimidazole 
(about 1.5 mL) was added to the reaction mixture in ice water 
and kept at 60 °C for 30 min. The mixture was subjected to 
GC analysis, run on a Shimadzu GC-14C gas chromatograph 
equipped with a 30 m × 0.32 mm i.d. 30QC2/AC-5 quartz 
capillary column and an H2 flame ionization detector with the 
following conditions: column temperature, 180280 °C;  
programmed increase, 3 °C/min; carrier gas, N2 (1 mL/min); 
injector and detector temperature, 250 °C; injection volume,  
4 μL; and split ratio, 1/50. The configuration of D-glucose,  
L-rhamnose, and D-fucose were determined by comparison of 
the retention time of the corresponding derivatives with those 
of standard D-glucose, L-rhamnose, and D-fucose, giving a 
peak at 18.576, 16.173, and 14.865 min, respectively. 
 
Cytotoxic Bioassay. The cytotoxicity assay was performed 
according to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] method,17 by use of the follow-
ing five human cancer cell lines: Human myeloid leukemia 
HL-60, hepatocellular carcinoma SMMC-7721, lung cancer  
A-549, breast cancer SK-BR-3, and pancreatic cancer PANC-1. 
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